A Novel Peptide Ameliorates LPS-Induced Intestinal Inflammation and Mucosal Barrier Damage via Its Antioxidant and Antiendotoxin Effects

Intestinal inflammation is an inflammatory disease resulting from immune dysregulation in the gut. It can increase the risk of enteric cancer, which is a common malignancy globally. As a new class of anti-inflammatory agents, native peptides have potential for use in the treatment of several intesti...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Mol Sci
Huvudupphovsmän: Zhang, Lulu, Wei, Xubiao, Zhang, Rijun, Si, Dayong, Petitte, James N., Ahmad, Baseer, Zhang, Manyi
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6720008/
https://ncbi.nlm.nih.gov/pubmed/31443263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20163974
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk